Sciele Pharma Inc: Premium Company Profile

Questions: Discounts, Updates etc.

Price: $495.00

Publication Date: 2007-12-25

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

The company was founded in 1992 as First Horizon Pharmaceutical and later in 2006, changed its name to Sciele Pharma. The company's therapeutic focus is on cardiovascular/metabolic and women's health.


Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Report Highlights
    Sciele Pharma engages in sales, marketing and development of branded prescription products. The company currently markets and sells 16 products, 10 of which are actively promoted. The company markets products related to indications cardiovascular, diabetes and women's health.

    Sciele Pharma's cardiovascular / diabetes related products include Altoprev, Fortamet, Nitrolingual, Triglide and sular and women's health related products include Optinate, Ostiva, Ponstel, Prenate Elite and Zovirax.

    The company's total revenues increased at a CAGR of 26% during 2002-2006, from $115 million to $293 million. The company's biggest contributor to revenue growth during 2002-2006 was sales of cardiovascular / diabetes related products - Altoprev, Fortamet, Nitrolingual, Triglide and sular.


    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    Other users found this report page using the following search terms: sciele pharma inc company competitors pharma fortamet list stock cheap

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.